The Yale Center for the Science of Cannabis and Cannabinoids recently released their list of inaugural Pilot Award winners.
A recent press release announced the Yale Center for the Science of Cannabis and Cannabinoids (YC-SCAN²) revealed their Pilot Award winners (1). The award program provides over $600,000 worth of grants to 14 researchers from the Yale School of Medicine. With these funds, researchers will be able to use them on a variety of projects that will study the effects cannabis and cannabinoids have on mental health and neurodevelopment. Once the research studies gather and review the data, the information is then made available so that the public, scientific community, and healthcare professionals are able to be educated on the data findings.
In 2023, YC-SCAN² was founded and aimed to provide a space for cannabis research and related studies such as, cannabinoids (1,2). Deepak Cyril D’Souza, MD, Vikram Sodhi ’92 Professor of Psychiatry, directs and manages the program.
“We received a highly competitive set of applications making for a challenging selection process,” D’Souza explained (1). We are grateful to our reviewers who brought their expertise in basic and clinical sciences in reviewing these applications.” He added that (1), “The projects cover a broad range of topics from the effects of cannabinoids on fetal neurodevelopment and adolescent brain development, the therapeutic potential of beta-caryophyllene for pain, to the impact of cannabis in schizophrenia,” he said. “The projects are led by investigators at different stages of their careers utilizing several novel approaches. We are optimistic that these projects will advance the science of cannabis and cannabinoids and bring Yale closer to the forefront of cutting-edge research in the area.”
As mentioned in the press release, funding for the grants was provided by Yale University. Here is a list of the recipients are (1):
References
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.